PL2490986T3 - Sposoby i systemy oczyszczania nieskompleksowanej neurotoksyny botulinowej - Google Patents

Sposoby i systemy oczyszczania nieskompleksowanej neurotoksyny botulinowej

Info

Publication number
PL2490986T3
PL2490986T3 PL10825598T PL10825598T PL2490986T3 PL 2490986 T3 PL2490986 T3 PL 2490986T3 PL 10825598 T PL10825598 T PL 10825598T PL 10825598 T PL10825598 T PL 10825598T PL 2490986 T3 PL2490986 T3 PL 2490986T3
Authority
PL
Poland
Prior art keywords
systems
methods
botulinum neurotoxin
purifying non
complexed botulinum
Prior art date
Application number
PL10825598T
Other languages
English (en)
Inventor
Curtis L. Ruegg
Original Assignee
Revance Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43879799&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2490986(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Revance Therapeutics, Inc. filed Critical Revance Therapeutics, Inc.
Publication of PL2490986T3 publication Critical patent/PL2490986T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL10825598T 2009-10-21 2010-10-20 Sposoby i systemy oczyszczania nieskompleksowanej neurotoksyny botulinowej PL2490986T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25381009P 2009-10-21 2009-10-21
EP10825598.5A EP2490986B2 (en) 2009-10-21 2010-10-20 Methods and systems for purifying non-complexed botulinum neurotoxin
PCT/US2010/053389 WO2011050072A1 (en) 2009-10-21 2010-10-20 Methods and systems for purifying non-complexed botulinum neurotoxin

Publications (1)

Publication Number Publication Date
PL2490986T3 true PL2490986T3 (pl) 2019-03-29

Family

ID=43879799

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10825598T PL2490986T3 (pl) 2009-10-21 2010-10-20 Sposoby i systemy oczyszczania nieskompleksowanej neurotoksyny botulinowej

Country Status (23)

Country Link
US (5) US20120196349A1 (pl)
EP (1) EP2490986B2 (pl)
JP (1) JP5951490B2 (pl)
KR (1) KR101819129B1 (pl)
CN (2) CN104961812B (pl)
AU (1) AU2010310749B2 (pl)
BR (1) BR112012009227A2 (pl)
CA (1) CA2773396C (pl)
CO (1) CO6551670A2 (pl)
CY (1) CY1120908T1 (pl)
DK (1) DK2490986T4 (pl)
ES (1) ES2688065T3 (pl)
HK (2) HK1175453A1 (pl)
HR (1) HRP20181869T1 (pl)
HU (1) HUE041599T2 (pl)
IL (2) IL218532A (pl)
LT (1) LT2490986T (pl)
MX (3) MX365496B (pl)
PL (1) PL2490986T3 (pl)
PT (1) PT2490986T (pl)
RS (1) RS58006B1 (pl)
SI (1) SI2490986T1 (pl)
WO (1) WO2011050072A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3332805T3 (da) 2008-12-31 2022-05-16 Revance Therapeutics Inc Injicerbare botulinumtoksinformuleringer
KR101975051B1 (ko) 2009-06-25 2019-05-03 레반스 테라퓨틱스, 아이엔씨. 알부민­불포함 보툴리눔 독소 제제
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
BR112012009227A2 (pt) 2009-10-21 2016-08-23 Revance Therapeutics Inc métodos e sistemas para purificar neurotoxina botulínica não complexada
KR101134146B1 (ko) * 2010-05-31 2012-04-19 메덱스젠 주식회사 국소 근마비 효과를 갖는 비확산형 보툴리눔 독소와 그의 정제방법
AU2014298922B2 (en) * 2013-07-30 2018-03-15 Merz Pharma Gmbh & Co. Kgaa Process for preparing a highly pure neurotoxic component of a botulinum toxin and uses thereof
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법
US9480731B2 (en) 2013-12-12 2016-11-01 Medy-Tox, Inc. Long lasting effect of new botulinum toxin formulations
GB201407525D0 (en) * 2014-04-29 2014-06-11 Syntaxin Ltd Manufacture of recombinant clostridium botulinum neurotoxins
GB201517450D0 (en) * 2015-10-02 2015-11-18 Ipsen Biopharm Ltd Method
KR101775682B1 (ko) 2015-11-30 2017-09-06 주식회사 대웅 보툴리눔 독소의 제조방법
KR102463881B1 (ko) * 2016-10-04 2022-11-07 (주)메디톡스 보툴리눔 독소 함유 용액으로부터 보툴리눔 독소를 분리하는 방법
EP3675900A4 (en) 2017-08-28 2021-05-05 Revance Therapeutics, Inc. TRANSMUCOSAL BOTULINUM TOXIN COMPOSITIONS, KITS, AND METHODS FOR TREATMENT OF BLADDER DISORDER
WO2020129986A1 (ja) * 2018-12-21 2020-06-25 一般財団法人阪大微生物病研究会 ボツリヌス毒素の製造方法
KR102485146B1 (ko) * 2019-04-15 2023-01-06 (주)제테마 보툴리눔 독소의 제조방법
KR102516203B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 제조방법
US10851363B1 (en) * 2019-05-22 2020-12-01 Boke Zhang Multilayer nano-cell containing biomolecules
KR20230009178A (ko) * 2021-07-08 2023-01-17 주식회사 파마리서치바이오 비-독소 단백질이 제거된 클로스트리디움 보툴리눔 신경독소 단백질의 정제방법
KR102512757B1 (ko) * 2021-07-22 2023-03-22 (주)이니바이오 정제 수율이 향상된 보툴리눔 독소 복합체 정제방법

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US796419A (en) 1904-07-18 1905-08-08 Carl Halbig Doll-head.
SE303567B (pl) * 1959-02-17 1968-09-02 Behringwerke Ag
US7214787B1 (en) * 1993-09-21 2007-05-08 United States Of America As Represented By The Secretary Of The Army Recombinant vaccine against botulinum neurotoxin
US5512547A (en) * 1994-10-13 1996-04-30 Wisconsin Alumni Research Foundation Pharmaceutical composition of botulinum neurotoxin and method of preparation
EP1053014A4 (en) * 1998-01-26 2004-11-10 Univ Massachusetts BIOLOGICALLY ACTIVE HEMAGGLUTININE TYPE A i (STRIDIUM BOTULINUM) AND METHOD FOR ITS USE
TW574036B (en) * 1998-09-11 2004-02-01 Elan Pharm Inc Stable liquid compositions of botulinum toxin
DE19925739A1 (de) * 1999-06-07 2000-12-21 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum mit einem Botulinum-Neurotoxin
GB9921592D0 (en) * 1999-09-13 1999-11-17 Microbiological Res Authority Preparation of highly pure toxin fragments
US20040220100A1 (en) * 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems
WO2002007773A2 (en) * 2000-07-21 2002-01-31 Essentia Biosystems, Inc. Multi-component biological transport systems
JP2003009897A (ja) * 2001-07-03 2003-01-14 Keiji Oguma ボツリヌス毒素の分離・精製法
GB2386246B (en) 2001-11-01 2005-06-29 Marconi Applied Techn Ltd Electron beam tube apparatus
ATE494367T1 (de) * 2002-12-18 2011-01-15 Hoffmann La Roche Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität
KR100498964B1 (ko) 2003-03-05 2005-07-01 삼성전자주식회사 이동단말에서의 전자파 흡수율 제어 방법 및 장치
WO2004108750A1 (en) * 2003-06-06 2004-12-16 Avecia Limited Process for the separation of proteins
US7452697B2 (en) * 2003-09-25 2008-11-18 Allergan, Inc. Chromatographic method and system for purifying a botulinum toxin
US8956812B2 (en) * 2003-12-30 2015-02-17 Bharat Biotech International Limited Process for the preparation and purification of recombinant proteins
KR20050074806A (ko) * 2004-01-14 2005-07-19 팜텍(주) 결정형 보툴리늄 독소의 제조방법
BRPI0508410B8 (pt) * 2004-03-03 2021-05-25 Revance Therapeutics Inc composições e métodos para a aplicação tópica e liberação transdérmica de toxinas botulínicas
AU2005251676B2 (en) * 2004-03-03 2011-09-29 Revance Therapeutics, Inc. Compositions and methods for topical diagnostic and therapeutic transport
MXPA06009853A (es) * 2005-03-03 2007-03-29 Allergan Inc Medios para bacteria de clostridium y procesos para obtener una toxina clostridial.
SI1891200T1 (sl) * 2005-06-17 2009-10-31 Merz Pharma Gmbh & Co Kgaa Naprava in postopek za izdelavo bioloĺ ko aktivnih spojin s fermentacijo
US8323666B2 (en) * 2005-08-01 2012-12-04 Allergan, Inc. Botulinum toxin compositions
AR061669A1 (es) * 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa Aplicacion de alta frecuencia de terapia con toxina botulinica
DK2085093T3 (en) * 2006-10-27 2015-06-01 Chemo Sero Therapeut Res Inst PREPARATION CONTAINING HIGHLY CLEANED BOTULIN TOXIN TYPE A OBTAINED FROM THE INFANT BOTULISM PATHOLOGY
CN100588706C (zh) * 2007-04-06 2010-02-10 常州千红生化制药股份有限公司 纯化弹性蛋白酶的方法
KR20100020971A (ko) * 2007-06-01 2010-02-23 메르츠 파마 게엠베하 운트 코. 카가아 고형 보툴리늄 톡신의 신경독 성분에 기초한 온도-안정한 근육 이완제를 제공하는 방법
JP5344558B2 (ja) * 2008-10-31 2013-11-20 国立大学法人 東京医科歯科大学 カチオン性ナノゲルを用いる粘膜ワクチン
DK3332805T3 (da) * 2008-12-31 2022-05-16 Revance Therapeutics Inc Injicerbare botulinumtoksinformuleringer
US8440204B2 (en) * 2009-04-30 2013-05-14 Wisconsin Alumni Research Foundation Subtype of Closteridium botulinum neurotoxin type A and uses thereof
KR101975051B1 (ko) * 2009-06-25 2019-05-03 레반스 테라퓨틱스, 아이엔씨. 알부민­불포함 보툴리눔 독소 제제
US8129139B2 (en) * 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
JP2011074025A (ja) * 2009-09-30 2011-04-14 Chemo-Sero-Therapeutic Research Inst ボツリヌス毒素の精製方法
BR112012009227A2 (pt) * 2009-10-21 2016-08-23 Revance Therapeutics Inc métodos e sistemas para purificar neurotoxina botulínica não complexada
US8440104B2 (en) * 2009-10-21 2013-05-14 General Electric Company Kimzeyite garnet phosphors
WO2013181576A2 (en) * 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods of evaluating and making biologics
MX370929B (es) * 2012-10-28 2020-01-08 Revance Therapeutics Inc Composiciones y usos de las mismas para el tratamiento seguro de la rinitis.
GB201407525D0 (en) * 2014-04-29 2014-06-11 Syntaxin Ltd Manufacture of recombinant clostridium botulinum neurotoxins
GB201517450D0 (en) * 2015-10-02 2015-11-18 Ipsen Biopharm Ltd Method
DK3368071T3 (da) * 2015-10-29 2022-05-02 Revance Therapeutics Inc Injicerbare botulinumtoksinformuleringer og fremgangsmåder til anvendelse deraf med langvarig terapeutisk eller kosmetisk virkning
KR101775682B1 (ko) * 2015-11-30 2017-09-06 주식회사 대웅 보툴리눔 독소의 제조방법
RU2019141383A (ru) * 2017-05-18 2021-06-18 Реванс Терапьютикс, Инк. (Revance Therapeutics, Inc.) Способы лечения цервикальной дистонии

Also Published As

Publication number Publication date
EP2490986B1 (en) 2018-08-08
AU2010310749B2 (en) 2016-02-11
EP2490986A1 (en) 2012-08-29
HK1175453A1 (en) 2013-07-05
SI2490986T1 (sl) 2018-12-31
PT2490986T (pt) 2018-11-13
LT2490986T (lt) 2018-11-26
IL218532A (en) 2016-10-31
MX2012004703A (es) 2012-06-08
CN102666396B (zh) 2015-05-13
IL248486A0 (en) 2016-12-29
AU2010310749A1 (en) 2012-03-29
RS58006B1 (sr) 2019-02-28
US20110092682A1 (en) 2011-04-21
HUE041599T2 (hu) 2019-05-28
BR112012009227A2 (pt) 2016-08-23
JP5951490B2 (ja) 2016-07-13
KR101819129B1 (ko) 2018-02-28
CN104961812A (zh) 2015-10-07
CN104961812B (zh) 2019-08-20
CO6551670A2 (es) 2012-10-31
US20150322419A1 (en) 2015-11-12
CN102666396A (zh) 2012-09-12
EP2490986A4 (en) 2013-11-13
US11466262B2 (en) 2022-10-11
IL218532A0 (en) 2012-07-31
US9469849B2 (en) 2016-10-18
DK2490986T3 (en) 2018-11-05
US20170029795A1 (en) 2017-02-02
US20200277591A1 (en) 2020-09-03
MX2019006519A (es) 2019-09-18
KR20120099431A (ko) 2012-09-10
JP2013508388A (ja) 2013-03-07
HK1215951A1 (zh) 2016-09-30
DK2490986T4 (da) 2024-06-17
ES2688065T3 (es) 2018-10-30
CY1120908T1 (el) 2019-12-11
EP2490986B2 (en) 2024-04-24
CA2773396A1 (en) 2011-04-28
CA2773396C (en) 2020-12-15
WO2011050072A1 (en) 2011-04-28
MX365496B (es) 2019-06-05
HRP20181869T1 (hr) 2019-01-11
US20120196349A1 (en) 2012-08-02

Similar Documents

Publication Publication Date Title
HRP20181869T1 (hr) Metode i sustavi za pročišćavanje nekompleksiranog botulinskog neurotoksina
HK1247629A1 (zh) 用於獲得肉毒桿菌神經毒素的方法和系統
TWI365145B (en) Method and system for asisting driver
EP2497193A4 (en) SYSTEM AND METHOD FOR MOBILE INTERACTION
EP2247366A4 (en) SYSTEMS AND METHODS FOR CO2 TREATMENT
GB2520198B (en) Method and systems for media consumption
EP2481217A4 (en) SYSTEM AND METHOD FOR MICROCLOUD COMPUTING
EP2456564A4 (en) GNSS CONTROL SYSTEM, IRRIGATION METHOD, AND APPLICATIONS THEREOF
EP2475950A4 (en) SYSTEM AND METHOD FOR BALLISTIC SOLUTIONS
EP2448809A4 (en) TRACK SYSTEM
IL207116A0 (en) System and method for location tracking
EP2457028A4 (en) REDUNDANT COOLING PROCESS AND SYSTEM
HK1148155A1 (en) Method and system for processing signal
PL2289767T3 (pl) Oparte na stabilności sposoby i układy sterowania kierowaniem
EP2395130A4 (en) METHOD AND SYSTEM FOR FACTORY OPERATION
IL215670A0 (en) Systems and methods for interrupted progam recording
ZA201200768B (en) System and method for vehicle performance control
IL214372A0 (en) Means and methods for manufacturing highly pure neurotoxin
EP2430514A4 (en) METHODS OF INTERACTING WITH INFORMATION AND MANIPULATION THEREOF AND RELATED SYSTEMS
HK1211954A1 (en) Method and system for polypeptide purification
GB2473109B (en) System and method for near-optimal media sharing
EP2457025A4 (en) METHOD AND SYSTEMS FOR IMPROVED COMBUSTION PROCESSES
ZA201201689B (en) System for determining unprocessed and partially processes neurotoxin type a
IL214218A0 (en) Systems and methods for bio-elecricity production
AU2009901043A0 (en) Travel system and method